Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review
Journal of Antimicrobial Chemotherapy, ISSN: 0305-7453, Vol: 55, Issue: 3, Page: 312-316
2005
- 97Citations
- 51Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations97
- Citation Indexes97
- 97
- CrossRef60
- Captures51
- Readers51
- 51
Review Description
Objective: In vitro susceptibility results of 29 clinical isolates of Rhodotorula spp. were analysed. In addition he susceptibility profile of another 102 Rhodotorula isolates was reviewed. Methods: The review included studies using antifungal susceptibility testing reference procedures or commercial methods exhibiting high correlation rates with reference procedures (Etest and Sensititre YeastOne). The 131 organisms analysed were 77 Rhodotorula mucilaginosa, 45 Rhodotorula glutinis and nine Rhodotorula spp. Results and conclusions: Fluconazole, itraconazole and voriconazole were inactive in vitro against the majority of isolates. Amphotericin B and flucytosine exhibited good activity, being reasonable alternatives for empirical treatment. Ravuconazole was more active in vitro than other azole agents and it could be considered as an extended-spectrum triazole and maybe as a therapeutic alternative in treating infections caused by Rhodotorula species. © The British Society for Antimicrobial Chemotherapy 2005; all rights reserved.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=15844419911&origin=inward; http://dx.doi.org/10.1093/jac/dki020; http://www.ncbi.nlm.nih.gov/pubmed/15695538; http://academic.oup.com/jac/article/55/3/312/758380/Susceptibility-profile-of-29-clinical-isolates-of; https://dx.doi.org/10.1093/jac/dki020; https://academic.oup.com/jac/article-abstract/55/3/312/758380?redirectedFrom=fulltext
Oxford University Press (OUP)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know